Vision RT reins in £250,000 for US push:
This article was originally published in Clinica
Executive Summary
London, UK-based 3D imaging specialist Vision RT has secured £250,000 ($504,000) in financing from new investor The Capital Fund in a bid to support its operations in the US. "We have recently appointed a director of sales, North America, who is establishing a direct sales and marketing presence for us in the US," company founder and CEO Dr Norman Smith told Clinica. The investment, which is part of a larger financing round, will also be used to further develop the company's patent-pending technology, the GateCT and GateRT 3D tracking platforms.